Antimicrobials 2016
 

SOCIAL FUNCTIONS

Howard Florey Reception

Date: Thursday 25 February 2016
Time: 1915 - 2045
Venue: Melbourne Exhibition Centre, Melbourne
Cost: Included in the full delegate registration fee.
Additional tickets may be purchased at a cost of $77 per person (inclusive of GST).


Industry Reception

Date: Friday 26 February 2016
Time: 1845 -2015
Venue: Melbourne Exhibition Centre, Melbourne
Cost: Included in the full delegate registration fee.
Additional tickets may be purchased at a cost of $77 per person (inclusive of GST).

INDUSTRY SESSIONS

INDUSTRY LUNCHEON SYMPOSIUM

Thursday 25 February 2016

MSD Luncheon Symposium

Title: Latest Advances in the Fight Against Serious Gram Negative Infections
Presenter: Yohei Doi,University of Pittsburgh, Division of Infectious Diseases, United States
                David Paterson, University of Queensland Centre for Clinical Research
Time: 1245 - 1415
Venue: Clarendon Auditorium, Level 2, Melbourne Exhibition Centre
Cost: Included in the full delegate registration fee.

Dr Yohei Doi
Dr Yohei Doi graduated from Nagoya University School of Medicine in Nagoya, Japan. After training in internal medicine at Anjo Kosei Hospital near Nagoya, he joined the National Institute of Infectious Diseases in Tokyo, Japan, as a staff researcher. During this period, he worked on characterization of novel antimicrobial resistance mechanisms in Gram-negative pathogens, including 16S ribosomal RNA methyltransferases and extended-spectrum AmpC beta-lactamses, under the mentorship of Dr. Yoshichika Arakawa.

He then moved to the United States in 2003 to pursue further clinical training, completing residency in categorical medicine at St. Luke’s Roosevelt Hospital Center in New York City. In 2005, he joined the University of Pittsburgh as a fellow, where he received training in clinical infectious diseases as well as clinical and translational research under the mentorship of Dr. David Paterson. Dr. Doi serves as an assistant professor of medicine at the University of Pittsburgh since 2008.

He has published over eighty articles in peer-reviewed journals and has mentored twenty students and trainees in his laboratory. His current research interests include the epidemiology of beta-lactamase-producing Escherichia coli, mechanisms of multidrug resistance in Acinetobacter baumannii and analysis of plasmids conferring multidrug resistance in various gram-negative species.

Prof David Paterson
David L. Paterson is a Professor of Medicine at The University of Queensland Centre for Clinical Research (UQCCR). He is also a Consultant Infectious Diseases Physician, Consultant Microbiologist and Medical Advisor for the Centre for Healthcare Related Infection Surveillance and Prevention (CHRISP). 

Professor Paterson's clinical work, research and teaching has been honoured and recognised internationally. He received both his medical degree and PhD from The University of Queensland. In 2007, Professor Paterson returned to Brisbane after spending ten years at The University of Pittsburgh School of Medicine, one of the leading academic medical institutions in The United States. His work at The University of Pittsburgh Medical Centre included appointments as Chief of Transplant Infectious Diseases and Director of the Antibiotic Management Program. In 2000 he was one of two recipients of the prestigious American Society for Microbiology (ASM) Merck Irving Sigal Memorial Award for "Significant Research in Microbiology and Infectious Diseases". He received the 2008 Frank Fenner Award for Advanced Research in Infectious Diseases by the Australasian Society for Infectious Diseases (ASID) and in 2009 he was the winner of a Queensland Health Senior Clinical Research Fellowship.

Friday 26 February 2016

MSD Luncheon Symposium

Title: Management and treatment of C-difficile infection in the immunocompromised host
Presenter: Oliver Cornely, CECAD - Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases, Cologne, Germany
Time: 1300 - 1430
Venue: Clarendon Auditorium, Level 2 Melbourne Exhibition Centre
Cost: Included in the full delegate registration fee.

Oliver Cornely was recently named Professor of Translational Research in the Cluster of Excellence in Cellular Stress Responses in Aging-Associated Diseases (CECAD) at the University of Cologne. He is also Professor of Internal Medicine and Consultant in Infectious Diseases at the Department I of Internal Medicine, at the Uniklinik Köln, Cologne, Germany. 

Dr. Cornely received his medical degree from the University Hospital at Albertus Magnus University, Cologne, in 1994, where he also completed his residency. He then became an intern at the St. Katharinen Hospital, Frechen, Germany. He is board certified in internal medicine, infectious diseases, haematology, oncology, and emergency medicine.

Originating from an HIV/AIDS clinical research group, Dr Cornely’s research interests include invasive fungal diseases in haematology/oncology and in the ICU setting, and multi-resistant organisms including Clostridium difficile. 

Dr Cornely is acting President of the European Confederation of Medical Mycology (ECMM), and past-President of the German-speaking Mycological Society. He currently serves on the Program Committee of the Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), and was recently appointed member of the Standards and Practice Guidelines Committee of the Infectious Diseases Society of America (IDSA). He is a reviewer for numerous medical scientific journals, editorial board member for Haematologica, Infectious Disease and Clinical Investigation, and Editor-in-Chief of Mycoses.


Saturday 27 February 2016

Illumina Luncheon Symposium

Title: Resolving resistance from sequence data: SRST2, ISMapper and Bandage
Presenters: Jane Hawkey, Bio21 Molecular Science & Biotechnology Institute, The University of Melbourne, Australia
                  Ryan Wick, Bio21 Molecular Science & Biotechnology Institute, The University of Melbourne, Australia
Time: 1230 - 1315
Venue: Clarendon Auditorium, Level 2, Melbourne Exhibition Centre
Cost: Included in the full delegate registration fee.

Ryan Wick is a research assistant in Dr Kathryn Holt's lab at the University of Melbourne's Centre for Systems Genomics. He is the developer of Bandage, a software tool for viewing genome assembly graphs which won a national iAward in 2015. He currently studies the genomes of bacterial pathogens with a particular interest in improving de novo genome assembly.

Jane Hawkey is a PhD student in Dr Kathryn Holt's lab in the Centre for Systems Genomics. Her research focuses on the evolutionary impact of mobile DNA elements in bacteria, concentrating on antibiotic resistance. She developed ISMapper, a command line tool for identifying insertion sequence sites from short read data. /span>


INDUSTRY BREAKFAST SYMPOSIA

Thursday 25 February 2016

bioMerieux Breakfast Symposium

Title: Antimicrobial Resistace - 1 World, 1 Fight!! 
Presenter: Alex van Belkum, bioMérieux Inc, France
Time: 0700 - 0845
Venue: Clarendon Rooms A/B, Level 5, Melbourne Exhibition Centre
Cost: Included in the full delegate registration fee.

Professor Alex van Belkum, PhDPhD, graduated as a biologist at the University of Leiden, The Netherlands in 1983. In 1988 he completed a PhD examination in Biochemistry at the same University. In 1996, he succeeded in a second PhD examination, subject Molecular Microbiology, at the Erasmus University, Rotterdam, The Netherlands.

Since 2011, Alex has worked for bioMérieux as R&D Director in the La Balme Microbiology Unit. In 2011, he became Corporate Vice President R&D Microbiology at bioMérieux (La Balme les Grottes, France). He there works within an international team of 130-150 researchers in the field of in vitro diagnostics in the field of primarily bacterial diseases.

Alex has (co)authored almost 500 PubMed-included manuscripts, over one hundred chapters in books and a variety of editorials, prefaces, letters etc, which have been cited over 25,000 times. The H-factor for Alex van Belkum is currently about 80. Van Belkum is Editor in Chief of the European Journal of Clinical Microbiology and Infectious Diseases.

Please note that this breakfast is now fully subscribed 


Friday 26 February 2016

BD Breakfast Symposium

Title: Automating the Microbiology Laboratory - Experiences and Learnings from Liverpool Hospital
Presenter: Dr Michael Maley, Liverpool Hospital, Australia
Time: 0700 - 0845
Venue: Clarendon Rooms A/B, Level 5, Melbourne Exhibition Centre
Cost: Included in the full delegate registration fee.

Please note that this breakfast is now fully subscribed


Saturday 27 February 2016

Cepheid Breakfast Symposium

Title: Optimising Patient Care: Experiences with the GeneXpert!             
Presenters: Dr Darren Jardine, St Vincent's Hospital Melbourne, Australia
                   Dr Amy Crowe, St Vincent's Hospital Melbourne, Australia
                   Katherine Ryan, The Royal Melbourne Hospital, Australia
                   Julie Creighton, Canterbury Health Laboratories, New Zealand
Time: 0700 - 0845
Venue: Clarendon Rooms A/B, Level 5, Melbourne Exhibition Centre
Cost: Included in the full delegate registration fee.

The Cepheid Breakfast Symposium will consist of four presentations:
"Integrating GeneXpert into a microbiology laboratory" - presented by Dr Darren Jardine
"“From laboratory results to optimising patient care: What does rapid mean beyond the laboratory?” - presented by Dr Amy Crowe
"The ripple effect of rapid and direct detection of VRE in a hospital setting" - presented by Katherine Ryan
"Hospital Beware: the patient who has travelled!" - presented by Julie Creighton

Please note that this breakfast is now fully subscribed